Gynura procumbens Root Extract Ameliorates Ischemia-Induced Neuronal Damage in the Hippocampal CA1 Region by Reducing Neuroinflammation
- PMID: 33435613
- PMCID: PMC7828071
- DOI: 10.3390/nu13010181
Gynura procumbens Root Extract Ameliorates Ischemia-Induced Neuronal Damage in the Hippocampal CA1 Region by Reducing Neuroinflammation
Abstract
Gynura procumbens has been used in Southeast Asia for the treatment of hypertension, hyperglycemia, and skin problems induced by ultraviolet irradiation. Although considerable studies have reported the biological properties of Gynura procumbens root extract (GPE-R), there are no studies on the effects of GPE-R in brain damages, for example following brain ischemia. In the present study, we screened the neuroprotective effects of GPE-R against ischemic damage and neuroinflammation in the hippocampus based on behavioral, morphological, and biological approaches. Gerbils received oral administration of GPE-R (30 and 300 mg/kg) every day for three weeks and 2 h after the last administration, ischemic surgery was done by occlusion of both common carotid arteries for 5 min. Administration of 300 mg/kg GPE-R significantly reduced ischemia-induced locomotor hyperactivity 1 day after ischemia. Significantly more NeuN-positive neurons were observed in the hippocampal CA1 regions of 300 mg/kg GPE-R-treated animals compared to those in the vehicle-treated group 4 days after ischemia. Administration of GPE-R significantly reduced levels of pro-inflammatory cytokines such as interleukin-1β, -6, and tumor necrosis factor-α 6 h after ischemia/reperfusion. In addition, activated microglia were significantly decreased in the 300 mg/kg GPE-R-treated group four days after ischemia/reperfusion compared to the vehicle-treated group. These results suggest that GPE-R may be one of the possible agents to protect neurons from ischemic damage by reducing inflammatory responses.
Keywords: Gynura procumbens root extract; ischemia; microglia; neuroprotection; pro-inflammatory cytokines.
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Neuroprotective effects of Alpinia katsumadai against experimental ischemic damage via control of oxidative stress.Pharm Biol. 2013 Feb;51(2):197-205. doi: 10.3109/13880209.2012.716853. Epub 2012 Oct 24. Pharm Biol. 2013. PMID: 23095174
-
Differential Effects of Pioglitazone in the Hippocampal CA1 Region Following Transient Forebrain Ischemia in Low- and High-Fat Diet-Fed Gerbils.Neurochem Res. 2015 May;40(5):1063-73. doi: 10.1007/s11064-015-1568-3. Epub 2015 Apr 19. Neurochem Res. 2015. PMID: 25894680
-
Laminarin Pretreatment Provides Neuroprotection against Forebrain Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Neuroinflammation in Aged Gerbils.Mar Drugs. 2020 Apr 15;18(4):213. doi: 10.3390/md18040213. Mar Drugs. 2020. PMID: 32326571 Free PMC article.
-
Current Knowledge Regarding Pharmacological Profile and Chemical Constituents of Gynura procumbens.Curr Top Med Chem. 2021;21(29):2671-2686. doi: 10.2174/1568026621666211004094902. Curr Top Med Chem. 2021. PMID: 34607545 Review.
-
IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.Br J Pharmacol. 2009 Jul;157(6):881-91. doi: 10.1111/j.1476-5381.2009.00256.x. Epub 2009 May 11. Br J Pharmacol. 2009. PMID: 19438508 Free PMC article. Review.
Cited by
-
Cissus verticillata Extract Decreases Neuronal Damage Induced by Oxidative Stress in HT22 Cells and Ischemia in Gerbils by Reducing the Inflammation and Phosphorylation of MAPKs.Plants (Basel). 2021 Jun 15;10(6):1217. doi: 10.3390/plants10061217. Plants (Basel). 2021. PMID: 34203930 Free PMC article.
References
-
- Bertolino G., de Araujo F.L., Souza H.C., Coimbra N.C., de Araujo J.E. Neuropathology and behavioral impairments after bilateral global ischemia surgery and exposure to static magnetic field: Evidence in the motor cortex, the hippocampal CA1 region and the neostriatum. Int. J. Radiat. Biol. 2013;89:595–601. doi: 10.3109/09553002.2013.784422. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous